Skip to main content

Platform

AEO Website Research-grade Content Content Factory About Audits Rankings Pricing

Resources

Knowledge Base Research FAQ
Audit
OverviewHow to ImproveScore BreakdownSite PagesGuides
iovance.com

iovance.com

Weak AI visibility with 22 of 48 criteria passing. Biggest gap: llms.txt file.

Biotech & PharmaceuticalsBiotechnology
48/100
F
Citation Avg
Answer Readiness
~40% weight
6/10
Content Structure
~25% weight
5/10
Trust & Authority
~15% weight
4/10
Technical Foundation
~10% weight
4/10
AI Discovery
~10% weight
4/10

Verdict

Below-average AEO readiness at 48/100 - multiple areas need attention. Key strengths include Table & List Extractability, Content Depth, and Answer-First Placement. Priority gaps: llms.txt File, Schema.org Structured Data, and Comprehensive FAQ Section.

#6341of 13363
View full rankings →
View improvement plan

How to Improve

Current
48/100
Projected
79/100
42Total Fixes
12Quick Wins
~97hEst. Effort
Quick Wins
Create /llms.txt fileStrengthen entity authority (NAP)Configure robots.txt for AI crawlersLink orphan pages into site navigationAdd definition-style contentAdd ai.txt and content licensingEnhance author and expert schemaFix canonical URL strategyImprove query-answer alignmentAdd visible date signalsClarify entity boundariesEliminate cross-page duplicate content
Create /llms.txt file
critical|low
Add llms-full.txt with extended content
medium|low
Fix HTML structure and meta tags
medium|low
Configure robots.txt for AI crawlers
critical|low
Fix canonical URL strategy
critical|low
Add internationalization signals
critical|medium
Create complete sitemap.xml
low|low
Reduce render-blocking resources
low|low
Improve server response efficiency
low|low

Top Opportunities10

Sections within pages contain identical or near-identical text. LLMs may flag this as low-quality or thin content, reducing citation authority. Rewrite duplicate blocks with unique angles.

Write concise, standalone answer paragraphs (2-3 sentences) immediately after question headings. These "snippet-ready" paragraphs are ideal for AI engine citations.

Publish original research, statistics, case studies, or proprietary data that AI engines can cite. Unique data points make your content a primary source rather than a derivative one.

Create a dedicated FAQ page with FAQPage schema markup. Cover common questions about your products, services, and industry to become a direct answer source for AI engines.

Add question-based headings (H2/H3) throughout your content. Use "What is...", "How does...", "Why should..." patterns that match how users query AI assistants.

Write 20-25 word self-contained answer sentences immediately after each H2 heading. 72.4% of AI-cited posts use this pattern - it gives engines a ready-made snippet to quote.

Add specific numbers, percentages, statistics, and data points throughout your content. Fact-dense content gives AI engines concrete data to cite rather than vague claims.

Ensure every question-format heading (H2/H3) is followed by a direct answer paragraph. This pattern is ideal for AI engine snippet extraction.

Include dateModified schema, visible last-updated dates, and time elements on content pages. Fresh content signals help AI engines prioritize your pages over stale alternatives.

Add inline citations to external sources, "According to [Source]..." attribution phrases, and a Sources section at the end of key articles.

Fix It With AI43

Your competitors are already optimizing for AI

Every day without action is traffic your site loses to AI-ready competitors. We fix that.

Fix My Score

Site Pages

www.iovance.com/scientific-publications-presentationsF36
Scientific Publications & Presentations - Iovance Biotherapeutics
www.iovance.com/managementF34
Management Biographies – Iovance Biotherapeutics
www.iovance.com/board-of-directorsF35
Board of Directors – Iovance Biotherapeutics
www.iovance.com/washington-health-data-privacy-noticeF30
Washington Health Data Privacy Notice - Iovance Biotherapeutics
www.iovance.com/next-generation-researchF35
T-cell Therapy Research – Iovance Biotherapeutics
www.iovance.com/patientsF33
Patient Recruitment for Clinical Trials - Iovance Biotherapeutics
www.iovance.com/about-iovance-biotherapeuticsF31
About Us – Iovance Biotherapeutics
www.iovance.com/clinical-trials/end-201D41
END-201 Study Overview
www.iovance.com/clinical-trialsF32
TIL Clinical Trials – Iovance Biotherapeutics
www.iovance.com/clinical-trials/?trial=CervicalCancerCF32
TIL Clinical Trials – Iovance Biotherapeutics
www.iovance.com/clinical-pipelineF34
Immuno-oncology Pipeline - Iovance Biotherapeutics
www.iovance.com/about-tilF34
Our Investigational TIL Therapy – Iovance Biotherapeutics
www.iovance.com/t-cell-therapy-platformsF31
T-cell Therapy and PBL Therapy Platforms – Iovance Biotherapeutics
www.iovance.com/cultureF31
www.iovance.com/research-partners-collaboratorsF33
Research Partners and Collaborators - Iovance Biotherapeutics
www.iovance.com/expanded-access-policyD40
Expanded Patient Access Policy - Iovance Biotherapeutics
www.iovance.com/manufacturingF31
Manufacturing tumor infiltrating lymphocyte (TIL) therapies – Iovance Biotherapeutics
www.iovance.com/iovance-cell-therapy-centerF35
Cell Therapy Center (iCTC) – Iovance Biotherapeutics
www.iovance.com/intellectual-propertyF29
T-cell-based Immunotherapy Intellectual Property – Iovance Biotherapeutics

Improve Your Score

Guides for the criteria with the most room for improvement

Related Questions

Browse all FAQs →

Want us to improve your score?

We build citation-ready content that AI engines choose as the answer.

Let's Talk